approval
saveDEFERASIROX — FDA approval
community read0 votes
Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalDEFERASIROX — FDA approvalOct 21, 2025 · 349d ago
- approvalDEFERASIROX — FDA approvalOct 21, 2025 · 349d ago
- approvalDEFERASIROX — FDA approvalOct 21, 2025 · 349d ago
- approvalDEFERASIROX — FDA approvalOct 21, 2025 · 349d ago
- approvalDEFERASIROX — FDA approvalOct 21, 2025 · 349d ago
- approvalDEFERASIROX — FDA approvalJan 26, 2016 · 3905d ago
same company · ±60 days · 6
- approvalDEFERASIROX: DEFERASIROX — FDA approvalOct 21, 2025
- approvalDEFERASIROX: DEFERASIROX — FDA approvalOct 21, 2025
- approvalDEFERASIROX: DEFERASIROX — FDA approvalOct 21, 2025
- approvalDEFERASIROX: DEFERASIROX — FDA approvalOct 21, 2025
- approvalDEFERASIROX: DEFERASIROX — FDA approvalOct 21, 2025
- approvalKapanol: MORPHINE SULFATE — FDA approvalOct 1, 2025
comments(0)
5-min edit window · permanent after that